Cognitive Behavioral Therapy for Prenatal Insomnia: A Randomized Controlled Trial.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 11 4 2019
medline: 23 2 2020
entrez: 11 4 2019
Statut: ppublish

Résumé

To evaluate the effectiveness of cognitive behavioral therapy for insomnia during pregnancy. Randomized, unmasked, 3-site controlled trial. Participants were randomly allocated to cognitive behavioral therapy for insomnia (a first-line, empirically supported psychosocial intervention that addresses sleep-related behaviors and cognitions) or a control intervention consisting of imagery exercises that paired patient-identified distressing nighttime experiences with patient-identified neutral images. Participants were eligible if they met diagnostic criteria for insomnia disorder and were between 18 and 32 weeks of gestation. Patients were ineligible if they met diagnostic criteria for major psychiatric disorders, including depression, or were receiving nonstudy treatments that could affect sleep (or both). The primary outcome was the Insomnia Severity Index score, a validated brief questionnaire, with scores between 14 and 21 representing clinically meaningful insomnia of moderate severity, scores higher than 21 representing severe insomnia, and scores less than 8 representing no insomnia. Secondary outcomes included remission of insomnia (Insomnia Severity Index score less than 8), objectively measured and self-reported time awake (ie, total wake time), and the Edinburgh Postnatal Depression Scale score. All outcomes were measured weekly. Analysis included 48 participants who did not complete treatment. We estimated that 184 women would be required to have 80% power, with a two-tailed test, to detect a moderate Cohen's d effect size (.5) with α=.05. Between May 2013 and April 2017, 194 pregnant women were randomized and 149 completed treatment; 179 with available baseline data (92%) were ultimately analyzed, 89 in the cognitive therapy group and 90 in the control group. Women assigned to cognitive behavioral therapy for insomnia experienced significantly greater reductions in insomnia severity (scores decreased from 15.4±4.3 to 8.0±5.2 in the cognitive behavioral therapy group vs from 15.9±4.4 to 11.2±4.9 in the control therapy group [P<.001, d=0.5]). Remission of insomnia (to an Insomnia Severity Index score less than 8) disorder was attained by 64% of women in the cognitive behavioral therapy for insomnia group vs 52% in the control group. Women receiving cognitive behavioral therapy for insomnia experienced faster remission of insomnia disorder, with a median of 31 days vs 48 days in the control therapy (P<.001). Cognitive behavioral therapy for insomnia led to significantly greater reduction in self-reported but not objective total wake time and a small but significantly greater decline in Edinburgh Postnatal Depression Scale scores vs the control group. Cognitive behavioral therapy for insomnia is an effective nonpharmacologic treatment for insomnia during pregnancy. ClinicalTrials.gov, NCT01846585.

Identifiants

pubmed: 30969203
doi: 10.1097/AOG.0000000000003216
pmc: PMC6485299
pii: 00006250-201905000-00010
doi:

Banques de données

ClinicalTrials.gov
['NCT01846585']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

911-919

Références

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Br J Psychiatry. 1990 Aug;157:288-90
pubmed: 2224383
BMC Pregnancy Childbirth. 2015 Jun 02;15:129
pubmed: 26031504
JAMA. 2001 Apr 11;285(14):1856-64
pubmed: 11308399
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
Obstet Gynecol. 2010 Jan;115(1):77-83
pubmed: 20027038
Ann Intern Med. 2016 Jul 19;165(2):125-33
pubmed: 27136449
Sleep. 2010 Apr;33(4):531-8
pubmed: 20394323
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
J Clin Psychiatry. 2016 Oct;77(10):e1316-e1323
pubmed: 27788313
Sleep. 2012 Feb 01;35(2):287-302
pubmed: 22294820
J Affect Disord. 2011 Dec;135(1-3):10-9
pubmed: 21300408
Int J Environ Res Public Health. 2011 Jan;8(1):15-20
pubmed: 21318011
Obstet Gynecol. 2016 Nov;128(5):964-971
pubmed: 27741179
BMJ. 2013 Mar 20;346:f1164
pubmed: 23516146
Sleep. 2006 Sep;29(9):1155-73
pubmed: 17040003
Sleep Breath. 2013 Dec;17(4):1323-7
pubmed: 23563909
Sleep Med Rev. 2016 Dec;30:1-10
pubmed: 26615572
J Psychosom Res. 2011 Apr;70(4):385-9
pubmed: 21414460
Clin Psychol Rev. 2005 Jul;25(5):593-611
pubmed: 15979771
Arch Gen Psychiatry. 2011 Oct;68(10):992-1002
pubmed: 21646568
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:70-75
pubmed: 29304393
Behav Sleep Med. 2012;10(3):152-66
pubmed: 22742434
Arch Womens Ment Health. 2006 Nov;9(6):309-15
pubmed: 17013761
Sleep. 2008 Apr;31(4):489-95
pubmed: 18457236
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Behav Sleep Med. 2017 Sep-Oct;15(5):377-393
pubmed: 27124405
Int J Methods Psychiatr Res. 2004;13(3):141-51
pubmed: 15297898
J Obstet Gynecol Neonatal Nurs. 2017 May - Jun;46(3):e95-e104
pubmed: 28343943
Sleep. 1987 Feb;10(1):45-56
pubmed: 3563247

Auteurs

Rachel Manber (R)

Stanford University, Stanford, California; Monash University, Melbourne, Australia; and Santa Clara Valley Medical Center, Fruitdale, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH